IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Dr. Agarwal's Health Care Ltd.
Issue Open Date 29-Jan-25  
Issue Closing Date 31-Jan-25  
Application Money 100  
Allotment Money  
Price Band 382 - 402  
Minimium Application No. 35  
Issue Size (Shares) 53526172  
Market Lot 1.00  
Objective
Our Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:1. Repayment/prepayment, in part or full, of certain of our borrowings; and2. General corporate purposes and unidentified inorganic acquisition
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   10889400   4307310   0.40  
Qualified Institutional Buyers   14519200   67361280   4.64  
Retail Individual Investors   25408599   10540285   0.41  
Business Description
We provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations,diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceuticalproducts. We h
more...
Promoter's Holding
Total Share Capital   116359650  
Offered to Public   75304970  
Promoter's Holding (Pre-Issue)   37.73  
Promoter's Holding (Post-Issue)   32.45  
Address
1st Floor
Buhari Towers
No.4
Moores Road
Off Greams Road
Near Asan Memorial School
Chennai ,
Tamil Nadu ,
600006
Phone: 044-43787777
Email: secretarial@dragarwal.com
Website: www.dragarwals.co.in
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE, NSE
Lead Manager
Jefferies India Pvt Ltd.
Kotak Mahindra Capital Co Ltd
Morgan Stanley India Co Pvt Ltd
Motilal Oswal Investment Advisors Pvt Ltd
Promoters
Adil Agarwal
Adil Agarwal Family Trust
Agarwal’S Eye Institute
Agarwals Eye Institute Pvt Ltd
Amar Agarwal
Amar Agarwal Family Trust
Anosh Agarwal
Anosh Agarwal Family Trust
Ashar Agarwal
Ashar Agarwal Family Trust
Ashvin Agarwal
Ashvin Agarwal Family Trust
Athiya Agarwal
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.